tirzepatide mechanism of action - an overview Tirzepatide: A New Obesity Treatment

Majority of the participants 70% shed at least 5% of their initial body weight after being under the highest dose of Qsymia for one year

[DOI] [PMC free article] [PubMed] [Google Scholar] 128.Mauro-Martn I.S., Collado-Yurrita L., Sanz-Rojo S., Lopez-Oliva S., Conty R., Puga A.M., Garicano-Vilar E

Introduction Recent decades have witnessed the conceptual evolution of the gastrointestinal tract from being solely a site of nutrient digestion and absorption to its recognition as the largest endocrine system in the body - more than 30 peptides are now known to be released from enteroendocrine cells within the gastrointestinal mucosa

The weight loss results appear to be the best ever documented for an obesity medication so far and should pave the way toward retatrutides regulatory approval in the near future